Recce Pharmaceuticals Ltd
OTC:RECEF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Recce Pharmaceuticals Ltd
OTC:RECEF
|
AU |
|
A
|
Allianz SE
F:ALV
|
DE |
|
Spire Global Inc
F:EL9
|
US |
|
Hydrogenpro ASA
OSE:HYPRO
|
NO |
|
S
|
Stroeer SE & Co KgaA
F:SAX
|
DE |
|
Lion Electric Co
F:70U
|
CA |
|
A
|
Aurania Resources Ltd
F:20Q
|
CA |
|
L
|
LyondellBasell Industries NV
F:DLY
|
UK |
|
W
|
Western Alliance Bancorp
F:WEA
|
US |
|
B
|
Burberry Group PLC
SWB:BB2
|
UK |
|
F
|
Fossil Group Inc
F:FSL
|
US |
|
L
|
Lenovo Group Ltd
XBER:LHL
|
CN |
Shareholder Yield
Current shareholder yield for 
RECEF is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
RECEF Price
Recce Pharmaceuticals Ltd
| Average Annual Return | 2.33% |
| Standard Deviation of Annual Returns | 26.74% |
| Max Drawdown | -63% |
| Market Capitalization | 164.8m USD |
| Shares Outstanding | 203 987 008 |
| Percentage of Shares Shorted |
N/A
|
